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ABSTRACT
Ewingella americana is a very rare cause of serious infections, especially in immunocompromised patients. We report a 
case of ventilator-associated pneumonia (VAP) in an intensive care unit patient, who was treated successfully with cef-
triaxone. To the best of our knowledge, this is the first case of VAP due to Ewingella americana in the English literature. 
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Ewingella americana’ya bağlı gelişen ventilator ilişkili pnömoni olgusu: Türkiye’den ilk 
vaka
ÖZET
Ewingella americana özellikle immunsuprese hastalarda ciddi enfeksiyonların çok ender bir sebebidir. Biz bu çalışmada 
bir yoğun bakım hastasında seftriaksonla başarı ile tedavi edilen bir ventilator ilişkili pnömoni olgusu sunduk. Bizim 
bilgimize göre bu vaka İngilizce literatürde Ewingella americana’nın etken olarak bildirildiği ilk ventilatör ilişkili pnömoni 
(VİP) olgusudur.
Anahtar kelimeler: Ewingella americana, ventilatör ilişkili pnömoni, yoğun bakım ünitesi
INTRODUCTION
Ewingella americana, which belongs to the Entero-
bacteriaceae family, is an extremely rare cause of 
nosocomial bacteremia, peritonitis associated with 
peritoneal dialysis, and conjunctivitis.1 Pneumonia 
caused by Ewingella americana were also report-
ed in an outpatient.2 and in an intensive care unit 
(ICU) patient.3 Here, we report a case of ventilator-
associated pneumonia (VAP); to the best of our 
knowledge, this is the first such case of VAP due to 
Ewingella americana to be reported in the English 
literature.
CASE
A 55 year old, Caucasian, male patient, who were 
diagnosed as myasthenia gravis five months pre-
viously, was admitted to the University Hospital of 
Kırıkkale, Turkey  with  insomnia  and  shortness  of 
breath. Thirty  minutes  after  admission,  he  devel-
oped cardiopulmonary arrest due to the involve-
ment of respiratory muscles. The patient respond-
ed to the cardiopulmonary resuscitation, and after 
endotracheal intubation, he was transferred to the 
ICU. At the admission, the patient did not have any 
physical or laboratory findings of infection. On the 
third day of admission, he developed fever and dys-
pnea. Purulent tracheal secretions were observed. 
On the physical examination, body temperature was 
38.7°C, heart rate 102/min, respiratory rate 26/min 
and arterial blood pressure 110/70 mmHg. Physical 
examinations were unremarkable except crepitant 
crackles on the right lower zone of the lung. Labora-
tory findings revealed; 6.300 leukocytes/mm³ (86% 
neutrophils), platelets 170.000 / mm³, hemoglobin 
11.4 g/dL, C-reactive protein 66 mg/L (reference 
range 0-5 mg/L) and normal hepatic and renal func-
tions.
The postero-anterior chest X-ray showed infil-
tration at the right lower zone. The patient was diag-Ecemis K, et al. Ventilator-Associated Pneumonia Caused 119
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nosed as VAP. After blood, urine and tracheal aspi-
rate cultures were obtained, the patient was treated 
empirically with meropenem (1 g every 8 hours) re-
garding to the antibiotic susceptibility pattern in the 
ICU. Tracheal aspirate culture revealed 1.000.000 
cfu/ml non-hemolytic Gram-negative bacilli on blood 
agar plate and lactose-negative colonies on eosine 
methylene blue (EMB) agar plate after 24 hours in-
cubation at 37°C. The isolate was identified as Ew-
ingella americana by VITEK 2 automated system. 
Urine and blood cultures did not reveal any bacte-
rial growth which were obtained during the initiation 
of antibacterial therapy. The strain was susceptible 
to ampicillin, amoxicillin/clavulanate, piperacillin/
tazobactam, cefuroxime, cefoxitin, cefixime, ceftazi-
dime, ceftriaxone, cefoperazone/sulbactam, ertape-
nem, imipenem, meropenem, amikacin, gentamicin, 
ciprofloxacin,  trimethoprim  /sulfamethoxazole. Ac-
cording to the antibiotic susceptibility pattern of the 
isolated bacteria, the meropenem therapy was de-
escalated to ceftriaxone (1 g every 12 hours). On 
the second day of antibiotherapy, the patient defer-
vesced, and the inflammation markers (C-reactive 
protein) declined. His antibiotic treatment was con-
tinued for 10 days. At the end of antibiotherapy the 
patient was still intubated due to his underlying con-
dition, but he had no signs or symptoms of infection.
DISCUSSION
Ewingella americana was first described by Grimont 
and coworkers in 1983.4 It is a rare bacteria with 
low pathogenic potential and usually effects immu-
nocompromised patients.2 
It can cause peritonitis, conjunctivitis, pneu-
monia, bacteremia and sepsis.2,5-9 A patient who 
died due to Waterhouse-Friderichsen syndrome, 
showed growth of Ewingella americana in the post-
mortem bacteriologic cultures, which shows the 
pathogenic potential of this bacteria.10 It may colo-
nize in wounds and sputum without causing clinical 
infection.2,11 Sputum was reported as the most com-
mon isolation sample and bacteremia as the most 
common infections due to Ewingella Americana.2
Ventilator-associated pneumonia (VAP) is an 
infection that occurs in an ICU patient more than 48 
hours after endotracheal intubation and mechanical 
ventilation. VAP remains a significant cause of pa-
tient morbidity and mortality.12 Only one pneumonia 
case in an ICU patient caused by Ewingella ameri-
cana has been reported to date, but this case was 
not defined as VAP.3 To our knowledge, our case 
is the first to be defined as VAP in the English lit-
erature. The strain was identified with VITEK-2 au-
tomated system and with this automatized system, 
more than %98 of the isolates can be correctly iden-
tified to the species level without any requirement of 
further testing.13 
Reported sources of infections have been iden-
tified as catheters, contaminated ice bath used in 
cardiovascular surgery and the hands of health-
care workers.8,14 Additionally, Ewingella americana 
caused an outbreak of pseudobacteremia owing 
to cross contamination of blood culture bottles with 
non-sterile blood collection tubes.6 In the present 
case, we carried out an extensive search to deter-
mine the source of infection. Hands and nasal cavi-
ties of the health-care workers who cared with the 
patient, the environment of the patient including the 
ventilation system, and the water circuit in the pa-
tient room were examined but the source of infec-
tion could not be identified.
Although Ewingella americana is generally sus-
ceptible to antibiotics, it can sometimes be multi-
drug resistant.3,5,15 Our patient’s isolate was suscep-
tible to all antibiotics tested.
This case revealed that Ewingella americana 
can cause VAP, especially in immunocompromised 
patients. However, more information is needed to 
clarify the pathogenicity of Ewingella americana.
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